Pearl River Capital, LLC Arvinas, Inc. Transaction History

Pearl River Capital, LLC

  • $625 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$36.01 - $74.24 $148,973 - $307,130
-4,137 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$60.27 - $81.57 $12,837 - $17,374
-213 Reduced 4.9%
4,137 $278,000
Q4 2021

Feb 11, 2022
BUY
$65.85 - $96.21 $286,447 - $418,513
4,350 New
4,350 $357,000

Others Institutions Holding ARVN

# of Institutions
224
Shares Held
68.7M
Call Options Held
166K
Put Options Held
31.3K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.31B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email